Sydney George

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 16

Top Topics

Preterm Infants

Peritoneal Dialysis

Physical Activity

Top Venues

PharmacoEconomics - open

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open (2024)
Sydney George, Jessica Regan, Amnah Awan, Meaghan O'Connor, April M Foster, Kimberly Raymond, Iris S Gorfinkel, Shelly A McNeil
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Human vaccines & immunotherapeutics 20 (1) (2024)
Sydney George, Jessica Regan, Amnah Awan, Meaghan O'Connor, April M Foster, Kimberly Raymond, Iris S Gorfinkel, Shelly A McNeil
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Human vaccines & immunotherapeutics 20 (1) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)
Sydney George, Jessica Regan, Amnah Awan, Meaghan O'Connor, April M Foster, Kimberly Raymond, Iris S Gorfinkel, Shelly A McNeil
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Human vaccines & immunotherapeutics 20 (1) (2024)
Sydney George, Jessica Regan, Amnah Awan, Meaghan O'Connor, April M Foster, Kimberly Raymond, Iris S Gorfinkel, Shelly A McNeil
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Human vaccines & immunotherapeutics 20 (1) (2024)
Sydney George, Justin Carrico, Katherine A Hicks, Dessi Loukov, Cheryl Ng, Jessica Regan, Nikolaos Giannelos
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older. PharmacoEconomics - open 8 (3) (2024)